Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vanda Pharmaceuticals Inc.    VNDA

Delayed Quote. Delayed  - 05/02 09:59:58 pm
8.89 USD   -0.11%
04/14 VANDA PHARMACEU : to Announce First Quarter 2016 Financial Results o..
02/16DJNew Drug Ads Tout Serious Conditions, Costly Treatments
02/10 VANDA PHARMACEU : reports 4Q loss
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/26/2016 04/27/2016 04/28/2016 04/29/2016 05/02/2016 Date
9.27(c) 9.08(c) 9.165(c) 8.9(c) 8.89(c) Last
565 709 363 040 642 693 521 758 410 128 Volume
-2.42% -2.05% +0.94% -2.89% -0.11% Change
More quotes
Financials ($)
Sales 2016 148 M
EBIT 2016 -36,3 M
Net income 2016 -37,8 M
Debt 2016 -
Yield 2016 -
Sales 2017 176 M
EBIT 2017 -3,61 M
Net income 2017 -5,75 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 2,60x
Capi. / Sales 2017 2,17x
Capitalization 384 M
More Financials
Company
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.Its products portfolio includes HETLIOZ, Fanapt and Tradipitant, Trichostatin and AQW051.Vanda Pharmaceuticals was founded by... 
More about the company
Surperformance© ratings of Vanda Pharmaceuticals Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on VANDA PHARMACEUTICALS INC.
04/21 VANDA PHARMACEUTICALS : to Announce First Quarter 2016 Financial Results on May ..
04/14 VANDA PHARMACEUTICALS : to Announce First Quarter 2016 Financial Results on May ..
04/04 VANDA PHARMACEUTICALS : Other Events (form 8-K)
02/25 VANDA PHARMACEUTICALS INC. : Can You Make Money With These Biotech Stocks? VNDA,..
02/18 VANDA PHARMACEUTICALS : Reports Fourth Quarter 2015 and Full Year 2015 Financial..
02/16DJNew Drug Ads Tout Serious Conditions, Costly Treatments
02/10 VANDA PHARMACEUTICALS : reports 4Q loss
02/10 VANDA PHARMACEUTICALS : Results of Operations and Financial Condition, Financial..
More news
Sector news : Bio Therapeutic Drugs
08:51aDJGilead Seeks to Tame Merck Case -- WSJ
05/02DJJudge Allows More Evidence in Patent Dispute After Gilead Says Merck Attorney..
05/02DJJudge Allows More Evidence in Patent Dispute After Gilead Says Merck Attorney..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
02/20 Tracking John Paulson's Paulson & Company Portfolio - Q4 2015 Update
02/16 Predicting Pipeline Of Pharma And Biotech
02/11 Vanda Pharma reports Q4 and FY15 results
02/10 Vanda Pharmaceuticals' (VNDA) CEO Mihael Polymeropoulos on Q4 2015 Results - ..
02/10 Vanda Pharmaceuticals (VNDA) Q4 2015 Results - Earnings Call Webcast


Comments 
Advertisement
Chart VANDA PHARMACEUTICALS INC.
Duration : Period :
Vanda Pharmaceuticals Inc. Technical Analysis Chart | VNDA | US9216591084 | 4-Traders
Full-screen chart
Technical analysis trends VANDA PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions